Neuroendocrine Prostate Cancer Market is segmented By Treatment (Chemotherapy, Hormonal Therapy), By...
Market Size in USD Mn
CAGR7.3%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 7.3% |
Market Concentration | Medium |
Major Players | Amgen, BioXcel Therapeutics, Oric Pharmaceuticals, Xencor, Astellas Pharma/Medivation and Among Others |
The neuroendocrine prostate cancer market is estimated to be valued at USD 1034.5 Mn in 2025 and is expected to reach USD 1694.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032. The increasing prevalence of prostate cancer globally is expected to drive the demand for effective treatment options.